Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.10.22.618551

Evidence for high-frequency parallel evolution in virulent A. baumannii cultures

Abstract

Acinetobacter baumannii, is a gram-negative opportunistic pathogen notorious for its antibiotic resistance and adaptability. These attributes present significant challenges in clinical infection management and failure to manage infection results in around 1,000,000 global deaths per year. A greater knowledge of the layers of regulation employed by such a versatile pathogen may yield an improved understanding of the factors important for A. baumannii survival in diverse conditions and then facilitate the development of countermeasures. This study initially began with the investigation of phenotypic changes in colony opacity under varying environmental conditions with experiments designed to probe aspects of virulence, motility, biofilm formation, and antibiotic resistance. Our initial data also suggest evidence for a phenotype driving mutation system which simultaneously occurred in multiple lineages at the same time. This genetic alteration was observed at higher than expected frequencies, seemingly providing a striking example of parallel evolution. Using proteomic profiling and PacBio sequencing, we characterized lineages of AB5075 which, following changes in culture conditions, grew into colonies of a split translucent/ opaque phenotype which was inherited by translucent and opaque progeny lineages. A genetic alteration in the capsule operon gene wzy, marked by an ISAba13 transposon insert, led to the downregulation of the wzy gene product. Translucent variants demonstrated denser sedimentation and reduced biofilm formation, whereas both opaque and translucent variants showed unexpectedly similar antibiotic resistance profiles, challenging the assumptions that capsule formation and antibiotic resistance are always linked. Our findings suggest that the adaptability and resistance mechanisms of A. baumannii are related but distinct, where capsule loss is part of a broader, adaptive strategy rather than a sole determinant of antibiotic susceptibility. These insights highlight the need for a nuanced therapeutic approach, considering the dynamic interplay of environmental cues, phenotypic changes, and genetic rearrangements. We believe that this study further opens a path for understanding the adaptability of A. baumannii and lays the groundwork for developing innovative therapeutic strategies against this resilient pathogen. Significance StatementThis study advances our understanding of the adaptability mechanisms of Acinetobacter baumannii, a pathogen notorious for its antibiotic resistance in clinical settings. We initially focused on the role of phenotype switches and identified genetic alterations in the Wzy operon that impact capsule production. Our studies led us to the surprising realization that we were observing multiple identical but independent evolution events. In addition, contrary to the traditional view that capsule variability directly correlates with antibiotic resistance, our findings revealed that susceptibility to aminoglycosides can occur independently of capsule loss, indicating capsule loss may be part of multiple survival strategies. These insights challenge existing paradigms and underscore the necessity for multiple therapeutic and preventative strategies that address the pathogens multifaceted adaptability for survival. Ultimately, this research contributes significantly to our knowledge of the biology of A. baumannii, paving the way for more effective management of infections caused by this formidable pathogen.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mclaughlin, J., Tobin, J. K., Hao, J., Bushnell, R. V., MacLeod, D. A., Wiggins, T. J., Zurawski, D. V., Tobin, G. J., Dollery, S. J.. 2024-10-23. Evidence for high-frequency parallel evolution in virulent A. baumannii cultures. https://doi.org/10.1101/2024.10.22.618551

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗